The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Mixed‐polarization phenotype of ascites‐associated macrophages in human ovarian carcinoma: Correlation of CD163 expression, cytokine levels and early relapse
Open accessAbstract
Ovarian cancer is typically accompanied by the occurrence of malignant ascites containing large number of macrophages. It has been suggested that these tumor‐associated macrophages (TAMs) are skewed to alternative polarization (M2) and thereby play an essential role in therapy resistance and metastatic spread. In our study, we have investigated the nature, regulation and clinical correlations of TAM polarization in serous ovarian cancer. Macrophage polarization markers on TAMs and ascites cytokine levels were analyzed for 30 patients and associated with relapse‐free survival (RFS) in a prospective study with 20 evaluable patients. Surface expression of the M2 marker CD163 on TAMs was inversely associated with RFS (p < 0.01). However, global gene expression profiles determined for 17 of these patients revealed a mixed‐polarization phenotype unrelated to the M1/M2 classification. CD163 surface expression also correlated with the ascites levels of IL‐6 and IL‐10 (p < 0.05), both cytokines induced CD163 expression, and their ascites levels showed a clear inverse association with RFS (p < 0.01). These findings define a subgroup of patients with high CD163 expression, high IL‐6 and/or IL‐10 levels and poor clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335
MANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528
Macrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
Tumour-educated macrophages promote tumour progression and metastasis
Pollard, J. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1256 · Cited by 3,367
Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis
Condeelis, J., & Pollard, J. W. (2006) · Cell · doi:10.1016/j.cell.2006.01.007 · Cited by 2,695
Ovarian Cancer Development and Metastasis
Lengyel, E. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.100105 · Cited by 1,672
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
Buechler, C., Ritter, M., Orsó, E., Langmann, T., Klucken, J., & Schmitz, G. (2000) · Journal of Leukocyte Biology · doi:10.1002/jlb.67.1.97 · Cited by 704
Biswas, S. K. (2006) · Blood · doi:10.1182/blood-2005-01-0428 · Cited by 696
Duluc, D., Delneste, Y., Tan, F., Moles, M.-P., Grimaud, L., Lenoir, J., Preisser, L., Anegon, I., Catala, L., Ifrah, N., et al. (2007) · Blood · doi:10.1182/blood-2007-02-072587 · Cited by 491
Systematic validation of specific phenotypic markers for in vitro polarized human macrophages
Ambarus, C. A., Krausz, S., van Eijk, M., Hamann, J., Radstake, T. R. D. J., Reedquist, K. A., Tak, P. P., & Baeten, D. L. P. (2012) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.10.013 · Cited by 411
The role of intratumoral and systemic IL-6 in breast cancer
Dethlefsen, C., Højfeldt, G., & Hojman, P. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2488-z · Cited by 363
Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy
Van Gorp, H., Delputte, P. L., & Nauwynck, H. J. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.008 · Cited by 357
Serum interleukin 6 as a prognostic factor in patients with prostate cancer.
Nakashima, J., Tachibana, M., Horiguchi, Y., Oya, M., Ohigashi, T., Asakura, H., & Murai, M. (2000) · PubMed · Cited by 351
The tumor-promoting actions of TNF-α involve TNFR1 and IL-17 in ovarian cancer in mice and humans
Charles, K. A., Kulbe, H., Soper, R., Escorcio-Correia, M., Lawrence, T., Schultheis, A., Chakravarty, P., Thompson, R. G., Kollias, G., Smyth, J. F., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39065 · Cited by 338
Bachelot, T., Ray-Coquard, I., Menetrier-Caux, C., Rastkha, M., Duc, A., & Blay, J.-Y. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600956 · Cited by 317
Dual role of macrophages in tumor growth and angiogenesis
Lamagna, C., Aurrand-Lions, M., & Imhof, B. A. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1105656 · Cited by 311
Zhang, G.-J., & Adachi, I. (1999) · PubMed · Cited by 306
HUMAN MONOCYTES EXPRESS CD163, WHICH IS UPREGULATED BY IL-10 AND IDENTICAL TO p155
Sulahian, T. H., Högger, P., Wahner, A. E., Wardwell, K., Goulding, N. J., Sorg, C., Droste, A., Stehling, M., Wallace, P. K., Morganelli, P. M., et al. (2000) · Cytokine · doi:10.1006/cyto.2000.0720 · Cited by 281
High-Resolution Transcriptome of Human Macrophages
Beyer, M., Mallmann, M. R., Xue, J., Staratschek-Jox, A., Vorholt, D., Krebs, W., Sommer, D., Sander, J., Mertens, C., Nino-Castro, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045466 · Cited by 258
Galizia, G., Orditura, M., Romano, C., Lieto, E., Castellano, P., Pelosio, L., Imperatore, V., Catalano, G., Pignatelli, C., & De Vita, F. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5163 · Cited by 227
Lan, C., Huang, X., Lin, S., Huang, H., Cai, Q., Wan, T., Lu, J., & Liu, J. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500312 · Cited by 227
A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment
Kulbe, H., Chakravarty, P., Leinster, D. A., Charles, K. A., Kwong, J., Thompson, R. G., Coward, J. I., Schioppa, T., Robinson, S. C., Gallagher, W. M., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2178 · Cited by 220
Lolmede, K., Campana, L., Vezzoli, M., Bosurgi, L., Tonlorenzi, R., Clementi, E., Bianchi, M. E., Cossu, G., Manfredi, A. A., Brunelli, S., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0908579 · Cited by 216
Kawamura, K., Komohara, Y., Takaishi, K., Katabuchi, H., & Takeya, M. (2009) · Pathology International · doi:10.1111/j.1440-1827.2009.02369.x · Cited by 210
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer
Scambia, G., Testa, U., Benedetti Panici, P., Foti, E., Martucci, R., Gadducci, A., Perillo, A., Facchini, V, Peschle, C., & Mancuso, S. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.71 · Cited by 198
Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients
Lane, D., Matte, I., Rancourt, C., & Piché, A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-210 · Cited by 190
Profiling of cytokines in human epithelial ovarian cancer ascites.
Matte, I., Lane, D. A., Laplante, C., Rancourt, C., & Piché, A. (2012) · Europe PMC (PubMed Central) · Cited by 188
Hassanzadeh Ghassabeh, G., De Baetselier, P., Brys, L., Noël, W., Van Ginderachter, J. A., Meerschaut, S., Beschin, A., Brombacher, F., & Raes, G. (2006) · Blood · doi:10.1182/blood-2005-04-1485 · Cited by 177
Takaishi, K., Komohara, Y., Tashiro, H., Ohtake, H., Nakagawa, T., Katabuchi, H., & Takeya, M. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01652.x · Cited by 170
Ashizawa, T., Okada, R., Suzuki, Y., Takagi, M., Yamazaki, T., Sumi, T., Aoki, T., Ohnuma, S., & Aoki, T. (2005) · Gastric Cancer · doi:10.1007/s10120-005-0315-x · Cited by 158
Chau, G., Wu, C.-W., Lui, W., Chang, T.-J., Kao, H.-L., Wu, L., King, K., Loong, C., Hsia, C.-Y., & Chi, C. (2000) · Annals of Surgery · doi:10.1097/00000658-200004000-00015 · Cited by 149
Serum Interleukin-10 Levels as a Prognostic Factor in Advanced Non-small Cell Lung Cancer Patients
Vita, F. D., Orditura, M., Galizia, G., Romano, C. P., Roscigno, A., Lieto, E., & Catalano, G. (2000) · CHEST Journal · doi:10.1378/chest.117.2.365 · Cited by 135
Torroella‐Kouri, M., Silvera, R., Rodríguez, D., Caso, R., Shatry, A. M., Opiela, S. J., Ilkovitch, D., Schwendener, R. A., Iragavarapu‐Charyulu, V., Cardentey, Y., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3427 · Cited by 134
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients
Petrovic, M. D., Čekerevac, I., Lazić, Z., & Zdravković, V. (2013) · European Respiratory Journal · doi:10.1183/13993003/erj.42.suppl_57.p2916 · Cited by 112
Rustin, G. J. S., Timmers, P. J., Nelstrop, A. E., Shreeves, G., Bentzen, S. M., Baron, B., Piccart, M. J., Bertelsen, K., Stuart, G. C. E., Cassidy, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.2757 · Cited by 102
Adhikary, T., Kaddatz, K., Finkernagel, F., Schönbauer, A., Meißner, W., Scharfe, M., Jarek, M., Blöcker, H., Müller‐Brüsselbach, S., & Müller, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016344 · Cited by 78
Self-citationKang, K., Robinson, G. W., & Hennighausen, L. G. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-4 · Cited by 71
Guo, L., Cui, Z., Zhang, J., & Huang, Y. (2011) · 癌症:英文版 · doi:10.5732/cjc.010.10490 · Cited by 62
Necula, L. G., Chivu‐Economescu, M., Stanciulescu, E.-L., Bleoţu, C., Dima, S., Alexiu, I., Dumitru, A., Constantinescu, G., Popescu, I., & Diaconu, C. C. (2012) · PubMed · Cited by 52
Li, W., Katz, B. P., & Spinola, S. M. (2012) · Infection and Immunity · doi:10.1128/iai.00912-12 · Cited by 50
Monocyte-derived IL-10 Expression Predicts Prognosis of Stage IV Melanoma Patients
Torisu‐Itakura, H., Lee, J. H., Huynh, Y., Ye, X., Essner, R., & Morton, D. L. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318158795b · Cited by 43
Cited by
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210
An Immune Atlas of Clear Cell Renal Cell Carcinoma
Chevrier, S., Levine, J. H., Zanotelli, V. R. T., Silina, K., Schulz, D., Bacac, M., Ries, C. H., Ailles, L., Jewett, M. A. S., Moch, H., et al. (2017) · Cell · doi:10.1016/j.cell.2017.04.016 · Cited by 1,004
Clinical significance of macrophage heterogeneity in human malignant tumors
Komohara, Y., Jinushi, M., & Takeya, M. (2014) · Cancer Science · doi:10.1111/cas.12314 · Cited by 551
Ahmed, N., & Stenvers, K. L. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00256 · Cited by 482
The Unique Molecular and Cellular Microenvironment of Ovarian Cancer
Worzfeld, T., Pogge von Strandmann, E., Huber, M., Adhikary, T., Wagner, U., Reinartz, S., & Müller, R. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00024 · Cited by 288
Self-citation
Metadata
- Authors
- Reinartz, S., Schumann, T., Finkernagel, F., Wortmann, A., Jansen, J. M., Meissner, W., Krause, M., Schwörer, A., Wagner, U., Müller‐Brüsselbach, S., & Müller, R.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2013-07-19
- Volume
- 134
- Issue
- 1
- Pages
- 32-42
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W1509070276
- Cited by
- 271
- References
- 45
- FWCI
- 7.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.